Issue 1/2013
Content (25 Articles)
Changes in Timing and kinematics of goal directed eye-hand movements in early-stage Parkinson’s disease
Danya Muilwijk, Simone Verheij, Johan JM Pel, Agnita JW Boon, Johannes van der Steen
Can we clinically diagnose dementia with Lewy bodies yet?
Yue Huang, Glenda Halliday
Short communication: genetic variations of SLC2A9 in relation to Parkinson’s disease
Jianjun Gao, Hong Xu, Xuemei Huang, Honglei Chen
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
Zhi-Kun Sun, Hong-Qi Yang, Sheng-Di Chen
Translational research in Huntington’s disease: opening up for disease modifying treatment
Jean-Marc Burgunder
Social brain dysfunctions in patients with Parkinson’s disease: a review of theory of mind studies
Rwei-Ling Yu, Ruey-Meei Wu
Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review
Xiao-dong Pan, Xiao-chun Chen
Quantitative evaluation of severity of behavioral and psychological symptoms of dementia in patients with vascular dementia
Wei-Dong Pan, Sohei Yoshida, Qian Liu, Chun-Lan Wu, Jun Wang, Jin Zhu, Ding-Fang Cai
Subthalamic nucleus deep brain stimulation for Parkinson’s disease: 8 years of follow-up
Dianyou Li, Chunyan Cao, Jing Zhang, Shikun Zhan, Shengdi Chen, Bomin Sun
Intranuclear inclusions in a fragile X mosaic male
Dalyir I Pretto, Michael R Hunsaker, Christopher L Cunningham, Claudia M Greco, Randi J Hagerman, Stephen C Noctor, Deborah A Hall, Paul J Hagerman, Flora Tassone
Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration
Joseph McInnes
Cell based therapy in Parkinsonism
Johannes PJM de Munter, Chongsik Lee, Erik Ch Wolters
Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells
Ali Zandieh, Maryam Izad, Mohammad Fakhri, Hamed Amirifard, Zahra Khazaeipour, Mohammad Hosein Harirchian
Biological function of Presenilin and its role in AD pathogenesis
Shuting Zhang, Mingming Zhang, Fang Cai, Weihong Song
Neurodegenerative changes initiated by presynaptic dysfunction
Toru Yasuda, Yasuto Nakata, Chi-Jing Choong, Hideki Mochizuki
Evidence of neurodegeneration in autism spectrum disorder
Janet K Kern, David A Geier, Lisa K Sykes, Mark R Geier
Progress of basic research in Parkinson’s disease in China: data mini-review from the National Natural Science Foundation
Heqi Cao, Gang Chen, Erdan Dong
Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
Kay Cheong Teo, Shu-Leong Ho
What does complement do in Alzheimer’s disease? Old molecules with new insights
Yong Shen, Libang Yang, Rena Li
Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts
Nady Braidy, Wei-Ping Gai, Ying Hua Xu, Perminder Sachdev, Gilles J Guillemin, Xing-Mai Jiang, J William O Ballard, Martin P Horan, Zhi Ming Fang, Beng H Chong, DanielKam Yin Chan
Asiaticoside, a trisaccaride triterpene induces biochemical and molecular variations in brain of mice with parkinsonism
Uvarajan Sampath, Vanisree Arambakkam Janardhanam
Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer’s disease
Shuk Wai Ho, Yuk Tung Chanel Tsui, Ting Ting Wong, Stanley Kwok-Kuen Cheung, William B Goggins, Lau Ming Yi, Kwok Kin Cheng, Larry Baum
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States
David A Geier, Brian S Hooker, Janet K Kern, Paul G King, Lisa K Sykes, Mark R Geier